METIS TECHBIO-P 07666·

Gross margin 56.14%--59.81%3.67%55.53%4.28%98.18%42.65% Net margin -92515.16%---6231.83%86283.34%-33684.08%27452.25%-373.18%33310.90% ROE 568.65%--59.53%509.13%36.11%23.42%-37.65%73.76% ROA -83.07%---44.31%38.76%-47.61%3.30%-30.37%17.24% Revenue growth ----1585.56%---84.13%1669.69%6985.02%7069.15% Attributable profit growth -----13.54%--14.22%27.76%21.51%7.29% Debt-to-assets 114.61%--174.43%59.82%231.84%57.41%19.33%212.51% Current ratio 0.69--10.459.767.492.966.670.82 Operating cash flow / net profit 0.27--0.330.060.480.150.310.17 Operating cash flow / revenue -24971.48%---2060.70%22910.78%-16141.03%14080.33%-115.80%16025.22%

Gross margin 78.04%--99.22%21.18% Net margin -16753.89%---99.30%16654.60% Revenue growth ----13398.86%-- Attributable profit growth ----19.99%-- Debt-to-assets ----8.94%-- Current ratio ----17.68-- Operating cash flow / net profit 0.50--1.060.56 Operating cash flow / revenue -8426.42%---105.12%8321.30%

Revenue 554.00K--9.34M1585.56%1.48M84.13%105.00M6985.02% Other income and gains 8.55M---53.88M730.19%14.94M127.73%19.93M33.42% Gross profit 311.00K--5.58M1695.82%823.00K85.26%103.09M12425.76% Selling and distribution expenses 18.10M--24.78M36.92%14.75M40.48%22.86M54.96% Administrative expenses 118.58M--85.47M27.92%90.56M5.96%196.04M116.47% Net finance costs 386.00K--78.37M20204.15%156.63M99.85%43.31M72.35% Income tax ----2.00K--8.00K300.00%123.00K1437.50% Operating profit -378.26M---449.41M18.81%-357.29M20.50%-361.61M1.21% Profit before tax -512.53M---581.93M13.54%-499.19M14.22%-391.71M21.53% Net profit -512.53M---581.93M13.54%-499.20M14.22%-391.84M21.51% Net profit attributable to owners -512.53M---581.93M13.54%-499.20M14.22%-391.84M21.51%

Revenue 1.14M--154.29M13398.86% Other income and gains 7.24M--6.15M15.00% Cost of sales 251.00K--1.20M378.49% Gross profit 892.00K--153.09M17062.67% Selling and distribution expenses 4.57M--21.27M365.03% Administrative expenses 56.38M--96.14M70.52% Net finance costs 27.51M--17.24M37.35% Income tax 0--3.18M-- Operating profit -163.99M---132.79M19.02% Profit before tax -191.50M---150.03M21.66% Net profit -191.50M---153.21M19.99% Net profit attributable to owners -191.50M---153.21M19.99%

Cash and cash equivalents 364.47M--561.47M54.05%557.64M0.68%828.26M48.53% Trade and bills receivables ----705.00K--268.00K61.99%181.00K32.46% Total current assets 419.96M--1.03B144.40%819.46M20.16%1.15B40.21% Total assets 616.98M--1.31B112.88%1.05B20.17%1.29B23.05% Total current liabilities 609.40M--98.21M83.88%109.43M11.42%172.21M57.37% Total liabilities 707.11M--2.29B223.99%2.43B6.11%249.41M89.74% Equity attributable to owners -90.13M---977.56M984.60%-1.38B41.41%1.04B175.29% Total equity -90.13M---977.56M984.60%-1.38B41.41%1.04B175.29%

Cash and cash equivalents ----2.53B-- Trade and bills receivables ----136.31M-- Total current assets ----3.03B-- Total assets ----3.31B-- Total current liabilities ----171.58M-- Total liabilities ----296.41M-- Equity attributable to owners ----3.02B-- Total equity ----3.02B--

Net cash from operating activities -138.34M---192.43M39.10%-239.21M24.31%-121.59M49.17% Net cash from investing activities 1.17M---404.89M34854.68%78.92M119.49%35.09M55.54% Net cash from financing activities 166.55M--799.94M380.29%143.31M82.08%369.48M157.82% Net change in cash 29.38M--202.62M589.71%-16.97M108.38%282.98M1767.13%

Net cash from operating activities -96.31M---162.20M68.40% Net cash from investing activities -53.65M---200.79M274.28% Net cash from financing activities 17.83M--2.09B11634.29% Net change in cash -132.13M--1.73B1409.12%